Portfolio / Okapi Bioscienes

Okapi.gif


Okapi Sciences was a Belgium based biopharmaceutical company focused on the licensing, development and commercialization of innovative antiviral drugs for livestock and pets.

Okapi was started by and spun out from the University of Leuven (KU Leuven). Okapi was acquired by Aratana Therapeutics Inc. in 2014.

Company:
okapi bioscienes

Fund: I

Status: realized

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

therapeutics

Icons-Creteria_Medical-technologymedical-devices.png